February 26, 2019
Ceva make appointments to manufacturing and supply, R&D leadership
As Ceva finalises its latest 2020-2025 strategic plan, it has also made "significant changes" to its leadership team, the veterinary health company announced recently.
Véronique Kodjo is appointed to the newly created position of global manufacturing and supply chain director and member of the executive committee of Ceva. Kodjo was a member of Boehringer Ingleheim's animal health executive committee and possesses a proven track record of leading strategic transformation in manufacturing, quality and supply chain in the complex animal health business.
Pascal Anjot, previously head of Ceva's pharmaceutical business unit, will assume the new role of innovation and research director, with responsibility for both vaccine, pharmaceutical and bio-pharmaceutical portfolio development. He remains a member of Ceva's management board.
Commenting on the changes, Ceva's chairman & CEO, Dr. Marc Prikazsky, said: "As we enter the year of Ceva's 20th anniversary, we face new set of challenges resulting from the tremendous growth we have enjoyed in previous years. Anticipating the future needs of our customers and our society as a whole has always been our key driver. Veronique will bring a fresh pair of eyes and invaluable experience to (ensure) that our industrial strategy matches this growth. At the same time, given the scientific convergence between research in biology and pharmaceuticals, Pascal will ensure that we focus our efforts on developing major products for the future".